53915-80-3Relevant academic research and scientific papers
Use of substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadizol-2-ones for inhibiting pancreatic lipase
-
Page 18, (2010/02/06)
The invention relates to a method for inhibiting pancreatic lipase, or the prophylaxis or treatment of obesity or diabetes mellitus of type 1 and 2, in a patient in need thereof, comprising administering to the patient a pharmaceutically effective amount of substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones of formula 1: wherein R1, R2, R3, R4 and R5 are as defined herein, or a prodrug, solvate, pharmacologically acceptable salt or acid addition salt thereof.
Synthesis, Reactions and Biological Activity o 3-p-(Sulphonamido)phenylsydnone and Its Derivatives
Tikare, Ravindra K.,Badami, Bharati V.,Puranik, Gurubasav S.
, p. 673 - 677 (2007/10/02)
Some new 3-p-(N,N-disubstituted sulphonamidophenylsydnones (19 - 24) have been synthesised.These sydnones on treatment with bromine, dimethyl acetylenedicarboxylate and dibenzoylacetylene give 4-bromosydnones (25 - 30), pyrazole dicarboxylates (31 - 36, 4
